Bradley E. Aouizerat's additional information
-
-
BS, Microbiology/ Molecular Genetics - University of California at Los AngelesPhD, Microbiology/ Molecular Genetics/lmmunology - University of California at Los AngelesMAS, Master of Advance Science Research in Clinical - University of California at San Francisco
-
-
Oral-systemic health
-
-
American Heart AssociationAmerican Liver FoundationAmerican Pain SocietyAmerican Society for Human GeneticsInternational Association for the Study of Pain
-
-
Faculty Honors Awards
Excellence in Research Mentoring Faculty Teaching Award (2013)Excellence in Research Mentoring Faculty Teaching Award (Nominee) (2012)Excellence in Research Mentoring Faculty Teaching Award (Nominee) (2011)Most Dedicated Mentor Award, PMCTR Fellowship Program (2009)Early Career Investigator Award, Bayer Healthcare International (2006)Multidisciplinary Clinical Research Scholar, Roadmap K12 (2006)Early Career Faculty Award, Hellman Family (2005)Faculty Mentorship Award Nominee (2005)Young Investigator Award, National Hemophilia Foundation (2005)National Liver Scholar Award, American Liver Foundation (2004)Irvine H. Page Young Investigator Award (Finalist), American Heart Association (2004)Faculty Mentorship Award Nominee (2004)Sam and Rose Gilbert Fellowship, UCLA (1998)Warsaw Fellowship (1998) -
-
Publications
Telomere length is associated with sleep duration but not sleep quality in adults with human immunodeficiency virus
Failed retrieving data.Trajectories of Depressive Symptoms in Women Prior to and for 6 Months After Breast Cancer Surgery
Failed retrieving data.Variations in potassium channel genes are associated with breast pain in women prior to breast cancer surgery
Failed retrieving data.Current and Emerging Technology Approaches in Genomics
Failed retrieving data.Cytokine gene variation is associated with depressive symptom trajectories in oncology patients and family caregivers
Failed retrieving data.Differences in depression, anxiety, and quality of life between women with and without breast pain prior to breast cancer surgery
Failed retrieving data.Differences in morning and evening fatigue in oncology patients and their family caregivers
Failed retrieving data.Differences in sleep disturbance, fatigue and energy levels between women with and without breast pain prior to breast cancer surgery
Failed retrieving data.Differences in the symptom experience of older versus younger oncology outpatients: A cross-sectional study
AbstractCataldo, J. K., Paul, S., Cooper, B., Skerman, H., Alexander, K., Aouizerat, B., Blackman, V., Merriman, J., Dunn, L., Ritchie, C., Yates, P., & Miaskowski, C. (2013). BMC Cancer, 13. 10.1186/1471-2407-13-6AbstractBackground: Mortality rates for cancer are decreasing in patients under 60 and increasing in those over 60 years of age. The reasons for these differences in mortality rates remain poorly understood. One explanation may be that older patients received substandard treatment because of concerns about adverse effects. Given the paucity of research on the multiple dimensions of the symptom experience in older oncology patients, the purpose of this study was to evaluate for differences in ratings of symptom occurrence, severity, frequency, and distress between younger (< 60 years) and older ( ≥ 60 years) adults undergoing cancer treatment. We hypothesized that older patients would have significantly lower ratings on four symptom dimensions.Methods: Data from two studies in the United States and one study in Australia were combined to conduct this analysis. All three studies used the MSAS to evaluate the occurrence, severity, frequency, and distress of 32 symptoms.Results: Data from 593 oncology outpatients receiving active treatment for their cancer (i.e., 44.4% were < 60 years and 55.6% were ≥ 60 years of age) were evaluated. Of the 32 MSAS symptoms, after controlling for significant covariates, older patients reported significantly lower occurrence rates for 15 (46.9%) symptoms, lower severity ratings for 6 (18.9%) symptoms, lower frequency ratings for 4 (12.5%) symptoms, and lower distress ratings for 14 (43.8%) symptoms.Conclusions: This study is the first to evaluate for differences in multiple dimensions of symptom experience in older oncology patients. For almost 50% of the MSAS symptoms, older patients reported significantly lower occurrence rates. While fewer age-related differences were found in ratings of symptom severity, frequency, and distress, a similar pattern was found across all three dimensions. Future research needs to focus on a detailed evaluation of patient and clinical characteristics (i.e., type and dose of treatment) that explain the differences in symptom experience identified in this study.Epigenetic Regulation and Measurement of Epigenetic Changes
Failed retrieving data.